PITAS film throat lozenges is imported by Taiho Pharma Asia Pacific and is manufactured by Taiho Pharmaceutical in Japan.
Taiho Pharma Asia Pacific was established in Singapore in August 2011 as a wholly-owned subsidiary of Taiho Pharmaceutical Co., Ltd. Sticking with our philosophy “by local. for local”, Taiho Pharma Asia Pacific covers a wide range of jobs such as clinical research, regulatory affairs, medical affairs and sales as a hub for Taiho’s oncology business in South East Asia in close touch with local medical oncologists and the other medical professionals in cancer care. Taiho Pharma Asia Pacific hopes to share our smile and happiness with local cancer patients, medical oncologists and the other medical professionals in cancer care in South East Asia by introducing our anticancer drugs and data with high quality. For more information about Taiho Pharma Asia Pacific, please visit https://www.taiho.com.sg/.
Taiho Pharmaceutical, a subsidiary of Otsuka Holdings Co., Ltd. (https://www.otsuka.com/en/), is an R&D-driven specialty pharma focusing on the fields of oncology, allergy and immunology, and urology. Its corporate philosophy takes the form of a pledge: “We strive to improve human health and contribute to a society enriched by smiles.”
In the field of oncology, in particular, Taiho Pharmaceutical is known as a leading company in Japan for developing innovative medicines for the treatment of cancer, a reputation that is rapidly expanding through their extensive global R&D efforts. In areas other than oncology, as well, the company creates and markets quality products that effectively treat medical conditions and can help improve people’s quality of life.
Always putting customers first, Taiho Pharmaceutical also aims to offer consumer healthcare products that support people’s efforts to lead fulfilling and rewarding lives.